Download Files:

BHA536

SKU T200350-25 mg Category Small Compound Brand: TargetMol

Price range: 5,984 CAD through 11,104 CAD

For Research Use Only (RUO). This product is sold strictly for laboratory research use. Not for human or veterinary consumption, therapeutic, or diagnostic use.For sale to research organizations and laboratories only; not for patients or for personal use.

Size

100 mg 25 mg 50 mg

Clear

Products Details

Product Description

– BHA536 is an orally effective inhibitor of PKCα/β and the NF-kB signaling pathway. This compound inhibits the proliferation of ABC DLBCL cells harboring CD79 mutations by causing cell cycle arrest in the G1 phase and induces apoptosis in TMD8 cells. Additionally, BHA536 exhibits antitumor activity in mice.

For Research Use Only (RUO). This product is sold strictly for laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic use. Any pharmacological, therapeutic, cosmetic, or biological effects described above are provided as research context only and do not represent intended or approved uses of this product.

Web ID

– T200350

Storage Temperature

– -20℃

Shipping

– Blue Ice

Molecular Formula

– C30H30ClN3O5

CAS Number

– 919992-85-1

Molecular Weight

– C30H30ClN3O5

SMILES

– O=C1NC(=O)C(C2=C(Cl)C=CC3=CC=C(C=C32)CN(C)C)=C1C4=CNC=5C(OCCOCCOC)=CC=CC45

Target

– LRRK2

Pathway

– NF-κB|||Chromatin/Epigenetic|||Apoptosis|||Cytoskeletal Signaling

Product type

– Small Compound

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.